News blog

First US patent for iPS cells

On 5 August, the United States Patent and Trademark Office approved its first patent for the induced pluripotent stem (iPS) cell technology developed by Kyoto University’s Shinya Yamanaka. The patent is based on the technique Yamanaka used in 2006 to reprogram fully differentiated somatic mouse cells to an embryonic state, but Akemi Nakamura a university spokeswoman says it will broadly cover variations of the technology developed since then in laboratories around the world for human cells.


Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.